Conrad, Curdin; Schlapbach, Christoph (2024). Prurigo nodularis forecast: light Th2 inflammation, with high chances of fibrosis. The Journal of allergy and clinical immunology, 153(1), pp. 93-94. Elsevier 10.1016/j.jaci.2023.11.003
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
1-s2.0-S0091674923014306-main.pdf - Accepted Version Restricted to registered users only until 11 November 2024. Available under License Publisher holds Copyright. Download (581kB) | Request a copy |
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology |
UniBE Contributor: |
Schlapbach, Christoph |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1097-6825 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
14 Nov 2023 17:03 |
Last Modified: |
08 Jan 2024 00:14 |
Publisher DOI: |
10.1016/j.jaci.2023.11.003 |
PubMed ID: |
37951309 |
Uncontrolled Keywords: |
Prurigo nodularis Th2 atopic dermatitis dupilumab fibrosis inflammation itch nemolizumab pruritus single-cell RNA sequencing type 2 inflammation |
BORIS DOI: |
10.48350/188813 |
URI: |
https://boris.unibe.ch/id/eprint/188813 |
Actions (login required)
 |
Edit item |